Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy

Xiaodan Jia1, Yue Wang1, Yue Qiao2

  • 1Research Center for Analytical Science, College of Chemistry, Nankai University, Tianjin 300071, P. R. China. xiuejiang@nankai.edu.cn.

Chemical Society Reviews
|October 21, 2024
PubMed

Insights

Nanomedicines offer novel strategies for cancer therapy by targeting tumor cell redox metabolism. This review explores nanomaterial-assisted approaches to regulate cancer cell metabolism, aiming to inhibit growth and overcome treatment resistance.

Area of Science:

  • Biochemistry
  • Oncology
  • Nanotechnology

Background:

  • Altered cellular redox metabolism is a key characteristic of cancer, driving tumor progression and therapeutic resistance.
  • Targeting tumor cell redox metabolism presents a promising therapeutic strategy for cancer treatment.
  • Nanomedicines have shown significant potential in modulating cancer cell metabolism.

Purpose of the Study:

  • To review recent advances in nanomaterial-assisted strategies for regulating tumor cell redox metabolism.
  • To focus on how nanomedicines modulate redox metabolism-related metabolite levels, enzyme activity, and signaling pathways.
  • To discuss future prospects and challenges in nanomedicine-based redox metabolism regulation for cancer therapy.

Main Methods:

  • Literature review of recent studies on nanomedicines and cancer redox metabolism.
  • Analysis of nanomaterial-assisted strategies targeting redox metabolism.
  • Discussion of implications for cancer treatment and nanomedicine development.

Main Results:

  • Nanomaterials offer unique advantages for regulating tumor cell redox metabolism.
  • Strategies focus on altering metabolite levels, enzyme activity, and signaling pathways.
  • These approaches hold promise for inhibiting tumor growth and reversing therapeutic resistance.

Conclusions:

  • Nanomaterial-assisted redox metabolism regulation is a rapidly advancing field in cancer therapy.
  • Further development is needed to address challenges and meet diverse cancer treatment demands.
  • These strategies are expected to play a crucial role in the future of nanomedicine for oncology.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K